Adhesive maker Elmer’s has reintroduced its trademark multipurpose household glue, Elmer’s Glue-All.
The new Glue-All is formulated to bond a wide variety of materials, including paper, fabric, wood, ceramic, cork and leather. To showcase the many uses of Glue-All, Elmer’s launched a series of how-to videos that feature a wide variety of household repair projects from the kitchen, bathroom, living room and garage, and will be available at Elmers.com and on YouTube.
A 4 fl. oz. bottle of Glue-All retails for around $1.99, and currently is available nationwide at major grocery stores, drug stores, big box retailers and craft stores.
Endicia announced the launch of its Internet postage solutions. Dymo printable postage sheets are self-adhesive, nondated label sheets that allow customers to print U.S. Postal Service-approved postage right from their computers, using any standard printer. Postage is easily purchased through an account, and Dymo stamps, a roll version of the sheet product, can be used with premium models of Dymo LabelWriter printers—providing the added bonus of printing one label at a time and thermal, ink-free printing technology.
“Now, small and medium-sized businesses can stock up on Dymo printable postage sheets from their local store and print postage using Endicia without the added cost of a monthly service fee,” said Amine Khechfe, general manager for Endicia.
Schnucks’ O’Brien to serve on Department of Agriculture advisory committee
ST. LOUIS An executive from Schnuck Markets will serve on an advisory committee of the Department of Agriculture, Schnucks said this week.
Agriculture secretary Tom Vilsack announced that Schnucks VP produce and floral Mike O’Brien would be one of 25 people appointed to a two-year term on the USDA’s Fruit and Vegetable Industry Advisory Committee. O’Brien is also vice chairman of the Produce Marketing Association.
“I am honred to represent Schnuck Markets and the retail produce industry as a member of this committee,” O’Brien said. “I am looking forward to the opportunity to contribute and to make a difference for families across the nation.”
The committee, originally chartered in 2001, advises the secretary of agriculture on industry issues related to fruits and vegetables.
Gilead commences phase 3 trial for single-tablet HIV treatment
FOSTER CITY, Calif. Gilead Sciences has started a late-stage clinical trial of an investigational 4-in-1 treatment for HIV, the drug maker said.
Gilead announced the initiation of a phase 3 trial of its “Quad” HIV drug, a single-tablet treatment that combines elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate. The study will compare the Quad regimen with the standard of care among adults with HIV-1 who have not taken antiretroviral treatments. The company is also investigating cobicistat as a standalone boosting agent for antiretroviral drugs.
“We are pleased to announce that the Quad phase 3 clinical program is underway,” Gilead EVP research and development and chief scientific officer Norbert Bischofberger said. “Efficacy and safety results from the phase 2 study suggest that the Quad may represent an important new option for patients with HIV.”